7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Diagnosis ... Tuberculosis Treatment ... Initiating Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Diagnosis ... Tuberculosis Treatment ... Initiating Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
polyangiitis), EGPA (eosinophilic ... differential (check eosinophil ... sparing of the lung ... #differential #diagnosis ... #management #treatment
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
pneumonia, Chronic eosinophilia ... pneumonia, Pulmonary ... Organizing Pneumonia Treatment ... #ILD #diagnosis ... #management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... rarely present with eosinophilic ... Neutrophilia • Eosinophilia ... macrophages Treatment ... #diagnosis #management
Toxocariasis
Pathogen: Toxocara - worldwide distributed helminth 
Transmission: 
 • Dogs and cats are the major source
migrate through the lungs ... larva migrans Diagnosis ... leukocytosis and eosinophilia ... #management #infectiousdiseases ... #treatment #microbiology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... muscarinic agonists • Active ... #Management